Phase I Study of UCART123 in Patient With Adverse Genetic Risk Acute Myeloid Leukemia

NCT04106076 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped The trial was discontinued due to sponsor's decision and not a consequence of any safety concern

Conditions

Interventions

Sponsor

Cellectis S.A.